Keywords: cardiovascular risk; inflammatory bowel disease; prediction model.
This study suggests that the current atherosclerotic cardiovascular disease risk prediction models used in clinical practice performed better in the non–inflammatory bowel disease (IBD) cohort compared with IBD, highlighting the need for a more specific risk prediction model tailored to the IBD population.